Drugs & Targets FDA approves longer-acting calaspargase pegol-mknl for ALL January 04, 2019Vol.45 No.01
Drugs & Targets European Commission adopted positive opinion of rucaparib in platinum-based chemotherapy December 14, 2018Vol.44 No.46
Drugs & Targets FDA grants orphan drug designation to Merck’s M7824 in biliary tract cancer December 14, 2018Vol.44 No.46
Drugs & Targets FDA approves Tecentriq + Avastin and carboplatin for initial treatment of specific type of metastatic lung cancer December 07, 2018Vol.44 No.45
Drugs & Targets FDA publishes draft guidance on class labeling of in vitro companion diagnostics for classes of drugs in oncology December 07, 2018Vol.44 No.45
Drugs & Targets FDA publishes framework document on real-world evidence December 07, 2018Vol.44 No.45
Drugs & Targets FDA grants Venclextra accelerated approval for newly-diagnosed AML November 30, 2018Vol.44 No.44
Drugs & Targets FDA approves Daurismo for newly-diagnosed AML in adults 75 years and older November 30, 2018Vol.44 No.44
Drugs & Targets FDA approves gilteritinib for relapsed or refractory AML with a FLT3 mutation November 30, 2018Vol.44 No.44
